This story sends readers off with the right take-home message, but could have done with a few more caveats and a better look at the big picture regarding the role of amyloid in Alzheimer’s disease.
This story has many of the same problems as the news release we reviewed on this topic.
There are two sides to every story, and this news release gives only one of them. The rosy description provided belies some big questions about how useful this test really is.
We like the way this story frames a less-invasive lung cancer test in terms of reduced costs and harms. But the piece really needed an independent expert to help sort out the evidence and provide context.
Tips for Understanding Studies